Solid Malignancy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-01-28
Clinical Trial Update: EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1) [Phase 1, Phase 2]
EMITT-1 is a Phase 1/2 clinical trial by Grey Wolf Therapeutics evaluating ERAP-mediated immunopeptidome targeting for advanced solid malign…